Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Hartmut Goldschmidt Dietger Niederwieser Hildegard Greinix |
| Publication date | July 20, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |